As our hair goes gray and our muscles weaken with age, our immune system also changes. In particular, the stem cells that ...

When Los Angeles anesthesiologist Dr. Nick Mondek learned his leukemia had returned earlier this year, he feared his options were running out.

Myeloid Therapeutics’ name no longer fits its pipeline. Having expanded beyond the eponymous myeloid cells, the biotech has rebranded as Create Medicines and committed to an R&D strategy that spans in ...

The most common type of liver cancer in children, hepatoblastoma, surprisingly appears to contain many immune cells from a type that has long been overlooked. This is according to a study by ...

By combining proteasome inhibitors with a second drug that disables one of two backup survival pathways, the team was able to ...

New research has discovered why a powerful leukemia drug eventually fails in most patients – and found a potential way to ...